Beta-synuclein
Beta-synuclein has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 9, 2024: “β-synuclein regulates the phase transitions and amyloid conversion of α-synuclein”.
- 1 lab in 1 country
- Funders: Huazhong University of Science and Technology and 4 more
- Model organisms1
What did studies of Beta-synuclein find?
2Studies of Beta-synuclein measured 2 outcomes; the most studied are lifespan (1 study) and movement defects (1).
Lifespan
upin worms1
1 study
Lifespan
upin worms1
Beta-synuclein extends lifespan in worms.
“Exogenous β-synuclein improves the movement defects and prolongs the lifespan of an α-synuclein-expressing NL5901 Caenorhabditis elegans strain”
Model organismsin an alpha-synuclein-expressing NL5901 strain
β-synuclein regulates the phase transitions and amyloid conversion of α-synuclein
Nature communications
Movement defects
upin worms1
1 study
Movement defects
upin worms1
Beta-synuclein improves movement defects in worms.
“Exogenous β-synuclein improves the movement defects and prolongs the lifespan of an α-synuclein-expressing NL5901 Caenorhabditis elegans strain”
Model organismsin an alpha-synuclein-expressing NL5901 strain
β-synuclein regulates the phase transitions and amyloid conversion of α-synuclein
Nature communications